Pricing Log in Create free account

Prima BioMed Ltd (IMMP) vs Kyntra Bio Inc (KYNB)

Prima BioMed Ltd and Kyntra Bio Inc are both Biotechnology companies. Prima BioMed Ltd and Kyntra Bio Inc are of similar size ($23.7M and $21.7M). Prima BioMed Ltd has negative trailing earnings, so its P/E is not meaningful; Kyntra Bio Inc trades at 0.1×. Across the 10 metrics below, Prima BioMed Ltd leads on 5 and Kyntra Bio Inc on 5.

Valuation

Metric IMMP KYNB Biotechnology median
P/E n/m 0.11 8.50
P/S n/m 4.25 9.71
P/B 0.05 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 16.35 9.21
Earnings yield (40.42%) 934.02% (33.15%)
Free cash flow yield (1,275.20%) (194.02%) (25.50%)

Profitability

Metric IMMP KYNB Biotechnology median
Gross margin — 6.28% 65.16%
Operating margin — (1,089.78%) 0.00%
Net margin — 3,967.77% 0.00%
Free cash flow margin 0.00% (824.19%) 0.00%
Return on equity 0.00% (157.83%) (56.36%)
Return on assets 0.00% 131.26% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IMMP KYNB Biotechnology median
Revenue growth (TTM) — (37.15%) 6.02%
EPS growth (last fiscal year) (33.84%) 478.08% 30.26%
Revenue growth, 5-year CAGR 40.79% (48.42%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMMP KYNB Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 2.97 2.69 4.72
Net debt to EBITDA 0.92 1.97 0.96

Dividend

Metric IMMP KYNB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IMMP KYNB Biotechnology median
Market cap 23.66m 21.70m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack